Healthcare -
Medical - Devices - NASDAQ - US
$ 1.64
2.5 %
$ 449 M
Market Cap
-1.12
P/E
1. INTRINSIC VALUE
Balance Sheet
Pacific Biosciences of California, Inc.
| Current Assets | 742 M |
| Cash & Short-Term Investments | 631 M |
| Receivables | 36.6 M |
| Other Current Assets | 74 M |
| Non-Current Assets | 1 B |
| Long-Term Investments | 12 M |
| PP&E | 69 M |
| Other Non-Current Assets | 923 M |
| Current Liabilities | 95 M |
| Accounts Payable | 15.1 M |
| Short-Term Debt | 10.1 M |
| Other Current Liabilities | 69.9 M |
| Non-Current Liabilities | 950 M |
| Long-Term Debt | 924 M |
| Other Non-Current Liabilities | 25.8 M |
EFFICIENCY
Earnings Waterfall
Pacific Biosciences of California, Inc.
| Revenue | 201 M |
| Cost Of Revenue | 148 M |
| Gross Profit | 52.8 M |
| Operating Expenses | 387 M |
| Operating Income | -334 M |
| Other Expenses | -27.7 M |
| Net Income | -307 M |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Pacific Biosciences of California, Inc.
| Net Income | -307 M |
| Depreciation & Amortization | 26.5 M |
| Capital Expenditures | -8.84 M |
| Stock-Based Compensation | 72.1 M |
| Change in Working Capital | -59 M |
| Others | -8.2 M |
| Free Cash Flow | -268 M |
Wall Street Analysts Price Targets
Pacific Biosciences of California, Inc.
Wall Street analysts predict an average 1-year price target for PACB of $3 , with forecasts ranging from
a
low of
$2 to a high of $4 .
PACB Lowest Price Target
Wall Street Target
2 USD
21.95%
PACB Average Price Target
Wall Street Target
3 USD
82.93%
PACB Highest Price Target
Wall Street Target
4 USD
143.90%
4. DIVIDEND
ANALYSIS
PACB does not distribute dividends.
5. COMPETITION
6. Ownership
Insider Ownership
Pacific Biosciences of California, Inc.
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
313 K USD 4
6-9 MONTHS
10.7 K USD 1
9-12 MONTHS
1.11 M USD 5
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
176 K USD 1
9-12 MONTHS
| Date | Value | Insider | Amount | Avg Price |
|---|---|---|---|---|
|
3 months ago
Sep 30, 2024
|
Sell 34.1 K
USD
|
Kim Susan G.
See Remarks
|
- 19782
|
1.722 USD |
|
4 months ago
Sep 16, 2024
|
Sell 173 K
USD
|
HENRY CHRISTIAN O
See Remarks
|
- 98907
|
1.746 USD |
|
5 months ago
Aug 19, 2024
|
Sell 42.6 K
USD
|
Eidel Jeff
See Remarks
|
- 26760
|
1.592 USD |
|
5 months ago
Aug 16, 2024
|
Sell 63.2 K
USD
|
Van Oene Mark
See Remarks
|
- 38011
|
1.662 USD |
|
8 months ago
May 20, 2024
|
Sell 10.7 K
USD
|
Farmer Michele
See Remarks
|
- 5275
|
2.03 USD |
|
10 months ago
Mar 06, 2024
|
Bought
176 K USD
|
Meline David W
Director
|
+ 40000
|
4.404 USD |
|
10 months ago
Mar 04, 2024
|
Sell 14.5 K
USD
|
Farmer Michele
See Remarks
|
- 2968
|
4.871 USD |
|
10 months ago
Mar 04, 2024
|
Sell 44.7 K
USD
|
Van Oene Mark
See Remarks
|
- 9186
|
4.871 USD |
|
10 months ago
Mar 04, 2024
|
Sell 25.7 K
USD
|
Kim Susan G.
See Remarks
|
- 5275
|
4.871 USD |
|
10 months ago
Mar 04, 2024
|
Sell 69.1 K
USD
|
HENRY CHRISTIAN O
See Remarks
|
- 14177
|
4.871 USD |
|
11 months ago
Feb 16, 2024
|
Sell 200 K
USD
|
Van Oene Mark
See Remarks
|
- 33560
|
5.958 USD |
|
11 months ago
Feb 16, 2024
|
Sell 92.3 K
USD
|
Eidel Jeff
See Remarks
|
- 15498
|
5.958 USD |
|
11 months ago
Feb 16, 2024
|
Sell 134 K
USD
|
Kim Susan G.
See Remarks
|
- 22496
|
5.958 USD |
|
10 months ago
Feb 20, 2024
|
Sell 4.37 K
USD
|
Kim Susan G.
See Remarks
|
- 831
|
5.261 USD |
|
11 months ago
Feb 16, 2024
|
Sell 471 K
USD
|
HENRY CHRISTIAN O
See Remarks
|
- 79038
|
5.958 USD |
|
10 months ago
Feb 20, 2024
|
Sell 10.4 K
USD
|
HENRY CHRISTIAN O
See Remarks
|
- 1979
|
5.261 USD |
|
11 months ago
Feb 16, 2024
|
Sell 45.1 K
USD
|
Farmer Michele
See Remarks
|
- 7562
|
5.958 USD |
|
1 year ago
Jan 09, 2024
|
Sell 241 K
USD
|
Van Oene Mark
See Remarks
|
- 31012
|
7.773 USD |
|
1 year ago
Dec 14, 2023
|
Sell 200 K
USD
|
HENRY CHRISTIAN O
See Remarks
|
- 20000
|
10 USD |
|
1 year ago
Sep 29, 2023
|
Sell 162 K
USD
|
Kim Susan G.
See Remarks
|
- 19257
|
8.437 USD |
|
1 year ago
Sep 18, 2023
|
Sell 980 K
USD
|
HENRY CHRISTIAN O
See Remarks
|
- 96844
|
10.122 USD |
|
1 year ago
Sep 11, 2023
|
Sell 105 K
USD
|
HENRY CHRISTIAN O
See Remarks
|
- 10000
|
10.452 USD |
|
1 year ago
Aug 17, 2023
|
Sell 105 K
USD
|
HENRY CHRISTIAN O
See Remarks
|
- 10000
|
10.5 USD |
|
1 year ago
Aug 17, 2023
|
Sell 275 K
USD
|
Eidel Jeff
See Remarks
|
- 25936
|
10.597 USD |
|
1 year ago
Aug 16, 2023
|
Sell 287 K
USD
|
Van Oene Mark
See Remarks
|
- 26102
|
11 USD |
|
1 year ago
May 18, 2023
|
Sell 65 K
USD
|
Farmer Michele
See Remarks
|
- 5165
|
12.59 USD |
|
1 year ago
Mar 15, 2023
|
Sell 67.1 K
USD
|
Ericson William W.
Director
|
- 7541
|
8.9 USD |
|
1 year ago
Mar 03, 2023
|
Sell 131 K
USD
|
HENRY CHRISTIAN O
See Remarks
|
- 13769
|
9.493 USD |
|
1 year ago
Mar 03, 2023
|
Sell 59.5 K
USD
|
Van Oene Mark
See Remarks
|
- 6268
|
9.493 USD |
|
1 year ago
Mar 03, 2023
|
Sell 47.9 K
USD
|
Kim Susan G.
See Remarks
|
- 5045
|
9.493 USD |
|
1 year ago
Mar 03, 2023
|
Sell 29.9 K
USD
|
Farmer Michele
See Remarks
|
- 3153
|
9.493 USD |
|
1 year ago
Feb 17, 2023
|
Sell 9.32 K
USD
|
Kim Susan G.
See Remarks
|
- 907
|
10.271 USD |
|
1 year ago
Feb 17, 2023
|
Sell 15.7 K
USD
|
HENRY CHRISTIAN O
See Remarks
|
- 1530
|
10.271 USD |
|
2 years ago
Jan 10, 2023
|
Sell 255 K
USD
|
Van Oene Mark
See Remarks
|
- 26722
|
9.534 USD |
|
2 years ago
Dec 01, 2022
|
Sell 488 K
USD
|
HENRY CHRISTIAN O
See Remarks
|
- 45000
|
10.844 USD |
|
2 years ago
Sep 29, 2022
|
Sell 72.8 K
USD
|
Kim Susan G.
See Remarks
|
- 12968
|
5.614 USD |
|
2 years ago
May 18, 2022
|
Sell 19.8 K
USD
|
Farmer Michele
See Remarks
|
- 3573
|
5.547 USD |
|
2 years ago
Feb 17, 2022
|
Sell 11.7 K
USD
|
Kim Susan G.
Chief Financial Officer
|
- 1062
|
11.06 USD |
|
2 years ago
Feb 17, 2022
|
Sell 23.5 K
USD
|
HENRY CHRISTIAN O
President & CEO
|
- 2122
|
11.09 USD |
|
2 years ago
Feb 16, 2022
|
Sell 37.7 K
USD
|
ORDONEZ KATHY
Director
|
- 3280
|
11.5 USD |
|
3 years ago
Jan 11, 2022
|
Sell 590 K
USD
|
Van Oene Mark
Chief Operating Officer
|
- 41480
|
14.23 USD |
|
3 years ago
Jan 11, 2022
|
Sell 282 K
USD
|
Fromen Peter
Chief Commercial Officer
|
- 19720
|
14.3 USD |
|
3 years ago
Sep 29, 2021
|
Sell 522 K
USD
|
Kim Susan G.
Chief Financial Officer
|
- 20272
|
25.75 USD |
|
3 years ago
Sep 16, 2021
|
Sell 2.44 M
USD
|
HENRY CHRISTIAN O
President & CEO
|
- 90520
|
26.91 USD |
|
3 years ago
Sep 16, 2021
|
Sell 2.44 M
USD
|
HENRY CHRISTIAN O
President & CEO
|
- 90520
|
26.91 USD |
|
3 years ago
May 25, 2021
|
Sell 947 K
USD
|
Ericson William W.
Director
|
- 36600
|
25.882 USD |
|
3 years ago
May 25, 2021
|
Sell 23.8 K
USD
|
Ericson William W.
Director
|
- 900
|
26.419 USD |
|
3 years ago
Feb 26, 2021
|
Sell 5.24 M
USD
|
Hunkapiller Michael
Director
|
- 170824
|
30.687 USD |
|
3 years ago
Feb 26, 2021
|
Sell 1.38 M
USD
|
Hunkapiller Michael
Director
|
- 43946
|
31.493 USD |
|
3 years ago
Feb 26, 2021
|
Sell 516 K
USD
|
Hunkapiller Michael
Director
|
- 15771
|
32.738 USD |
|
3 years ago
Feb 26, 2021
|
Sell 123 K
USD
|
Hunkapiller Michael
Director
|
- 3705
|
33.33 USD |
|
3 years ago
Feb 25, 2021
|
Sell 3.43 M
USD
|
Hunkapiller Michael
Director
|
- 110515
|
31.045 USD |
|
3 years ago
Feb 24, 2021
|
Sell 3.11 M
USD
|
Hunkapiller Michael
Director
|
- 87349
|
35.586 USD |
|
3 years ago
Feb 24, 2021
|
Sell 2.02 M
USD
|
Hunkapiller Michael
Director
|
- 55399
|
36.413 USD |
|
3 years ago
Feb 25, 2021
|
Sell 3.94 M
USD
|
Hunkapiller Michael
Director
|
- 123383
|
31.971 USD |
|
3 years ago
Feb 25, 2021
|
Sell 767 K
USD
|
Hunkapiller Michael
Director
|
- 23331
|
32.877 USD |
|
3 years ago
Feb 24, 2021
|
Sell 2.71 M
USD
|
Hunkapiller Michael
Director
|
- 72303
|
37.466 USD |
|
3 years ago
Feb 25, 2021
|
Sell 1.69 M
USD
|
Hunkapiller Michael
Director
|
- 49410
|
34.209 USD |
|
3 years ago
Feb 25, 2021
|
Sell 1.02 M
USD
|
Hunkapiller Michael
Director
|
- 29500
|
34.728 USD |
|
3 years ago
Feb 24, 2021
|
Sell 1.97 M
USD
|
Hunkapiller Michael
Director
|
- 51376
|
38.359 USD |
|
3 years ago
Feb 25, 2021
|
Sell 116 K
USD
|
Hunkapiller Michael
Director
|
- 3238
|
35.68 USD |
|
3 years ago
Feb 23, 2021
|
Sell 745 K
USD
|
Hunkapiller Michael
Director
|
- 24100
|
30.898 USD |
|
3 years ago
Feb 23, 2021
|
Sell 907 K
USD
|
Hunkapiller Michael
Director
|
- 28595
|
31.706 USD |
|
3 years ago
Feb 23, 2021
|
Sell 602 K
USD
|
Hunkapiller Michael
Director
|
- 18259
|
32.975 USD |
|
3 years ago
Feb 23, 2021
|
Sell 1.45 M
USD
|
Hunkapiller Michael
Director
|
- 42378
|
34.224 USD |
|
3 years ago
Feb 22, 2021
|
Sell 2.13 M
USD
|
Hunkapiller Michael
Director
|
- 57260
|
37.172 USD |
|
3 years ago
Feb 23, 2021
|
Sell 3.98 M
USD
|
Hunkapiller Michael
Director
|
- 113308
|
35.101 USD |
|
3 years ago
Feb 22, 2021
|
Sell 1.28 M
USD
|
Hunkapiller Michael
Director
|
- 33491
|
38.082 USD |
|
3 years ago
Feb 22, 2021
|
Sell 1.5 M
USD
|
Hunkapiller Michael
Director
|
- 38360
|
39.146 USD |
|
3 years ago
Feb 23, 2021
|
Sell 2.67 M
USD
|
Hunkapiller Michael
Director
|
- 74119
|
35.992 USD |
|
3 years ago
Feb 22, 2021
|
Sell 2.33 M
USD
|
Hunkapiller Michael
Director
|
- 57902
|
40.284 USD |
|
3 years ago
Feb 22, 2021
|
Sell 1.73 M
USD
|
Hunkapiller Michael
Director
|
- 42114
|
41.064 USD |
|
3 years ago
Feb 23, 2021
|
Sell 2.67 M
USD
|
Hunkapiller Michael
Director
|
- 72562
|
36.847 USD |
|
3 years ago
Feb 22, 2021
|
Sell 151 K
USD
|
Schaefer Eric
Chief Accounting Officer
|
- 3842
|
39.2 USD |
|
3 years ago
Feb 16, 2021
|
Sell 5.65 M
USD
|
ORDONEZ KATHY
Director
|
- 118667
|
47.584 USD |
|
3 years ago
Feb 16, 2021
|
Sell 4.9 M
USD
|
ORDONEZ KATHY
Director
|
- 101004
|
48.466 USD |
|
3 years ago
Feb 16, 2021
|
Sell 53.9 K
USD
|
ORDONEZ KATHY
Director
|
- 1100
|
49 USD |
|
3 years ago
Feb 12, 2021
|
Sell 5.12 M
USD
|
Shapiro Lucy
Director
|
- 101666
|
50.4 USD |
|
3 years ago
Feb 12, 2021
|
Sell 3.24 M
USD
|
LIVINGSTON RANDALL S
Director
|
- 67500
|
48.066 USD |
|
3 years ago
Feb 12, 2021
|
Sell 7.68 M
USD
|
Botstein David
Director
|
- 154858
|
49.608 USD |
|
3 years ago
Feb 12, 2021
|
Sell 258 K
USD
|
Botstein David
Director
|
- 5142
|
50.091 USD |
|
3 years ago
Jan 25, 2021
|
Sell 182 K
USD
|
Hunkapiller Michael
Director
|
- 5167
|
35.167 USD |
|
3 years ago
Jan 25, 2021
|
Sell 3 M
USD
|
Hunkapiller Michael
Director
|
- 83241
|
36.006 USD |
|
3 years ago
Jan 25, 2021
|
Sell 1.19 M
USD
|
Hunkapiller Michael
Director
|
- 32082
|
37.166 USD |
|
3 years ago
Jan 25, 2021
|
Sell 186 K
USD
|
Hunkapiller Michael
Director
|
- 4916
|
37.766 USD |
|
3 years ago
Jan 21, 2021
|
Sell 1.03 M
USD
|
Hunkapiller Michael
Director
|
- 29049
|
35.436 USD |
|
4 years ago
Jan 20, 2021
|
Sell 5.48 M
USD
|
Hunkapiller Michael
Director
|
- 141199
|
38.789 USD |
|
3 years ago
Jan 21, 2021
|
Sell 4.13 M
USD
|
Hunkapiller Michael
Director
|
- 113472
|
36.392 USD |
|
3 years ago
Jan 22, 2021
|
Sell 1.62 M
USD
|
Hunkapiller Michael
Director
|
- 45165
|
35.916 USD |
|
4 years ago
Jan 20, 2021
|
Sell 1.73 M
USD
|
Hunkapiller Michael
Director
|
- 43846
|
39.345 USD |
|
4 years ago
Jan 20, 2021
|
Sell 978 K
USD
|
Hunkapiller Michael
Director
|
- 24032
|
40.69 USD |
|
3 years ago
Jan 21, 2021
|
Sell 2.3 M
USD
|
Hunkapiller Michael
Director
|
- 61834
|
37.18 USD |
|
3 years ago
Jan 21, 2021
|
Sell 26.6 K
USD
|
Hunkapiller Michael
Director
|
- 700
|
38.055 USD |
|
3 years ago
Jan 21, 2021
|
Sell 143 K
USD
|
Hunkapiller Michael
Director
|
- 3656
|
39.085 USD |
|
4 years ago
Jan 20, 2021
|
Sell 246 K
USD
|
Hunkapiller Michael
Director
|
- 5949
|
41.405 USD |
|
3 years ago
Jan 22, 2021
|
Sell 2.6 M
USD
|
Hunkapiller Michael
Director
|
- 70377
|
36.948 USD |
|
3 years ago
Jan 21, 2021
|
Sell 865 K
USD
|
Hunkapiller Michael
Director
|
- 23817
|
36.303 USD |
|
3 years ago
Jan 22, 2021
|
Sell 1.33 M
USD
|
Hunkapiller Michael
Director
|
- 35315
|
37.521 USD |
|
3 years ago
Jan 21, 2021
|
Sell 965 K
USD
|
Hunkapiller Michael
Director
|
- 25993
|
37.128 USD |
|
4 years ago
Dec 21, 2020
|
Sell 283 K
USD
|
Hunkapiller Michael
Director
|
- 13870
|
20.378 USD |
|
4 years ago
Dec 21, 2020
|
Sell 360 K
USD
|
Hunkapiller Michael
Director
|
- 16698
|
21.549 USD |
|
4 years ago
Dec 22, 2020
|
Sell 1.57 M
USD
|
Hunkapiller Michael
Director
|
- 64195
|
24.392 USD |
|
4 years ago
Dec 21, 2020
|
Sell 1.2 M
USD
|
Hunkapiller Michael
Director
|
- 52923
|
22.675 USD |
|
4 years ago
Dec 22, 2020
|
Sell 4.38 M
USD
|
Hunkapiller Michael
Director
|
- 172242
|
25.412 USD |
|
4 years ago
Dec 22, 2020
|
Sell 2.38 M
USD
|
Hunkapiller Michael
Director
|
- 90459
|
26.336 USD |
|
4 years ago
Dec 21, 2020
|
Sell 5.67 M
USD
|
Hunkapiller Michael
Director
|
- 243544
|
23.287 USD |
|
4 years ago
Dec 22, 2020
|
Sell 1.01 M
USD
|
Hunkapiller Michael
Director
|
- 37555
|
26.908 USD |
|
4 years ago
Dec 21, 2020
|
Sell 204 K
USD
|
Hunkapiller Michael
Director
|
- 8514
|
24.01 USD |
|
4 years ago
Nov 24, 2020
|
Sell 21.5 K
USD
|
Hunkapiller Michael
Director
|
- 1492
|
14.385 USD |
|
4 years ago
Nov 20, 2020
|
Sell 2.23 M
USD
|
Hunkapiller Michael
Director
|
- 147799
|
15.112 USD |
|
4 years ago
Nov 23, 2020
|
Sell 3.79 M
USD
|
Hunkapiller Michael
Director
|
- 251837
|
15.032 USD |
|
4 years ago
Nov 18, 2020
|
Sell 603 K
USD
|
Hunkapiller Michael
Director
|
- 38381
|
15.711 USD |
|
4 years ago
Nov 19, 2020
|
Sell 34.2 K
USD
|
Hunkapiller Michael
Director
|
- 2201
|
15.55 USD |
|
4 years ago
Nov 16, 2020
|
Sell 675 K
USD
|
Hunkapiller Michael
Director
|
- 42488
|
15.895 USD |
|
4 years ago
Nov 10, 2020
|
Sell 18.6 M
USD
|
Hunkapiller Michael
Director
|
- 1304348
|
14.25 USD |
|
4 years ago
Nov 11, 2020
|
Sell 2.79 M
USD
|
Hunkapiller Michael
Director
|
- 195652
|
14.25 USD |
|
4 years ago
Nov 11, 2020
|
Sell 4.12 M
USD
|
Hunkapiller Michael
Director
|
- 250000
|
16.464 USD |
|
4 years ago
Nov 12, 2020
|
Sell 3.35 M
USD
|
Hunkapiller Michael
Director
|
- 200000
|
16.729 USD |
|
4 years ago
Aug 24, 2020
|
Sell 1.72 M
USD
|
Hunkapiller Michael
CEO & President
|
- 259164
|
6.6347 USD |
|
4 years ago
Aug 25, 2020
|
Sell 1.47 M
USD
|
Hunkapiller Michael
CEO & President
|
- 228632
|
6.441 USD |
|
4 years ago
Aug 20, 2020
|
Sell 1.66 M
USD
|
Hunkapiller Michael
CEO & President
|
- 256554
|
6.4696 USD |
|
4 years ago
Aug 21, 2020
|
Sell 1.25 M
USD
|
Hunkapiller Michael
CEO & President
|
- 189847
|
6.568 USD |
|
4 years ago
Mar 24, 2020
|
Sell 8.42 K
USD
|
Phillips James Michael
SVP, Research & Development
|
- 2760
|
3.051 USD |
|
4 years ago
Feb 19, 2020
|
Sell 55.8 K
USD
|
BARNES SUSAN K
EVP, CFO and PAO
|
- 12558
|
4.44 USD |
|
4 years ago
Feb 20, 2020
|
Sell 22.6 K
USD
|
Phillips James Michael
SVP, Research & Development
|
- 5050
|
4.48 USD |
|
4 years ago
Feb 20, 2020
|
Sell 750 K
USD
|
Hunkapiller Michael
Chairman, CEO & President
|
- 166575
|
4.501 USD |
|
4 years ago
Feb 18, 2020
|
Sell 2.36 M
USD
|
Hunkapiller Michael
Chairman, CEO & President
|
- 525995
|
4.493 USD |
|
4 years ago
Feb 19, 2020
|
Sell 342 K
USD
|
Hunkapiller Michael
Chairman, CEO & President
|
- 76281
|
4.488 USD |
|
5 years ago
Feb 19, 2019
|
Sell 51.8 K
USD
|
Phillips James Michael
SVP, Research & Development
|
- 7231
|
7.166 USD |
|
5 years ago
Feb 19, 2019
|
Sell 49.7 K
USD
|
ORDONEZ KATHY
Director
|
- 6933
|
7.168 USD |
|
5 years ago
Feb 19, 2019
|
Sell 85.9 K
USD
|
BARNES SUSAN K
EVP, CFO and PAO
|
- 11987
|
7.162 USD |
|
5 years ago
Feb 19, 2019
|
Sell 95.8 K
USD
|
Hunkapiller Michael
Chairman, CEO & President
|
- 13335
|
7.186 USD |
|
6 years ago
Nov 27, 2018
|
Sell 188 K
USD
|
ORDONEZ KATHY
Chief Commercial Officer
|
- 25000
|
7.54 USD |
|
8 years ago
Oct 28, 2016
|
Sell 169 K
USD
|
Phillips James Michael
SVP, Research & Development
|
- 20000
|
8.436 USD |
|
8 years ago
Jul 29, 2016
|
Sell 169 K
USD
|
Phillips James Michael
SVP, Research & Development
|
- 20000
|
8.446 USD |
|
8 years ago
Apr 25, 2016
|
Sell 206 K
USD
|
Phillips James Michael
SVP, Research & Development
|
- 20000
|
10.286 USD |
|
9 years ago
Aug 07, 2015
|
Sell 77 K
USD
|
Phillips James Michael
SVP, Research & Development
|
- 16689
|
4.6144 USD |
|
9 years ago
Mar 02, 2015
|
Bought
9.22 K USD
|
Phillips James Michael
SVP, Research & Development
|
+ 1877
|
4.913 USD |
|
9 years ago
Mar 02, 2015
|
Bought
13.8 K USD
|
CORCORAN KEVIN P
SVP, Market Development
|
+ 2816
|
4.913 USD |
|
9 years ago
Mar 02, 2015
|
Bought
12.3 K USD
|
Dow Brian B
VP and PAO
|
+ 2503
|
4.913 USD |
|
10 years ago
Aug 11, 2014
|
Bought
698 K USD
|
Ericson William W.
Director
|
+ 143300
|
4.8703 USD |
|
10 years ago
Aug 08, 2014
|
Bought
252 K USD
|
Ericson William W.
Director
|
+ 51423
|
4.8957 USD |
|
10 years ago
Aug 07, 2014
|
Bought
698 K USD
|
Ericson William W.
Director
|
+ 146265
|
4.7731 USD |
|
10 years ago
Aug 06, 2014
|
Bought
117 K USD
|
Ericson William W.
Director
|
+ 24761
|
4.7367 USD |
|
10 years ago
Aug 05, 2014
|
Bought
530 K USD
|
Ericson William W.
Director
|
+ 114321
|
4.6395 USD |
|
10 years ago
Jun 12, 2014
|
Bought
274 K USD
|
Ericson William W.
Director
|
+ 45875
|
5.9679 USD |
|
10 years ago
Jun 10, 2014
|
Bought
359 K USD
|
Ericson William W.
Director
|
+ 68921
|
5.2112 USD |
|
10 years ago
Aug 19, 2014
|
Bought
202 K USD
|
Ericson William W.
Director
|
+ 39299
|
5.1398 USD |
|
10 years ago
Aug 18, 2014
|
Bought
687 K USD
|
Ericson William W.
Director
|
+ 135155
|
5.0867 USD |
|
10 years ago
Aug 14, 2014
|
Bought
389 K USD
|
Ericson William W.
Director
|
+ 77822
|
4.9954 USD |
|
10 years ago
Aug 13, 2014
|
Bought
145 K USD
|
Ericson William W.
Director
|
+ 29435
|
4.9252 USD |
|
10 years ago
Aug 12, 2014
|
Bought
604 K USD
|
Ericson William W.
Director
|
+ 123423
|
4.8935 USD |
|
11 years ago
Dec 12, 2013
|
Bought
229 K USD
|
Hunkapiller Michael
Chairman, CEO & President
|
+ 55087
|
4.1574 USD |
|
11 years ago
Dec 11, 2013
|
Bought
184 K USD
|
Hunkapiller Michael
Chairman, CEO & President
|
+ 44913
|
4.0971 USD |
|
11 years ago
Nov 21, 2013
|
Bought
722 K USD
|
Hunkapiller Michael
Chairman, CEO & President
|
+ 200000
|
3.6084 USD |
|
12 years ago
Dec 03, 2012
|
Bought
99 K USD
|
Hunkapiller Michael
Chairman, CEO & President
|
+ 56700
|
1.7455 USD |
|
12 years ago
Nov 30, 2012
|
Bought
171 K USD
|
Hunkapiller Michael
Chairman, CEO & President
|
+ 97400
|
1.7585 USD |
|
12 years ago
Nov 29, 2012
|
Bought
169 K USD
|
Hunkapiller Michael
Chairman, CEO & President
|
+ 97400
|
1.7368 USD |
|
12 years ago
Nov 28, 2012
|
Bought
164 K USD
|
Hunkapiller Michael
Chairman, CEO & President
|
+ 97400
|
1.682 USD |
|
12 years ago
Nov 27, 2012
|
Bought
73.6 K USD
|
Hunkapiller Michael
Chairman, CEO & President
|
+ 47400
|
1.5535 USD |
|
12 years ago
Nov 26, 2012
|
Bought
145 K USD
|
Hunkapiller Michael
Chairman, CEO & President
|
+ 97400
|
1.4918 USD |
|
12 years ago
Nov 23, 2012
|
Bought
72.3 K USD
|
Hunkapiller Michael
Chairman, CEO & President
|
+ 50000
|
1.4468 USD |
|
12 years ago
Nov 21, 2012
|
Bought
51.6 K USD
|
Hunkapiller Michael
Chairman, CEO & President
|
+ 39000
|
1.323 USD |
|
12 years ago
Nov 20, 2012
|
Bought
83.3 K USD
|
Hunkapiller Michael
Chairman, CEO & President
|
+ 65600
|
1.2693 USD |
|
12 years ago
Nov 19, 2012
|
Bought
113 K USD
|
Hunkapiller Michael
Chairman, CEO & President
|
+ 89400
|
1.2623 USD |
|
12 years ago
Nov 16, 2012
|
Bought
121 K USD
|
Hunkapiller Michael
Chairman, CEO & President
|
+ 100000
|
1.2119 USD |
|
12 years ago
Nov 15, 2012
|
Bought
169 K USD
|
Hunkapiller Michael
Chairman, CEO & President
|
+ 150000
|
1.1235 USD |
|
12 years ago
Nov 14, 2012
|
Bought
13.9 K USD
|
Hunkapiller Michael
Chairman, CEO & President
|
+ 12300
|
1.1297 USD |
|
12 years ago
Aug 07, 2012
|
Bought
608 K USD
|
Hunkapiller Michael
Chairman, CEO & President
|
+ 347500
|
1.75 USD |
|
12 years ago
Aug 06, 2012
|
Bought
91.7 K USD
|
Hunkapiller Michael
Chairman, CEO & President
|
+ 52500
|
1.7459 USD |
|
13 years ago
Aug 10, 2011
|
Bought
170 K USD
|
Hunkapiller Michael
Director
|
+ 30000
|
5.6766 USD |
|
13 years ago
Aug 09, 2011
|
Bought
407 K USD
|
Hunkapiller Michael
Director
|
+ 70000
|
5.813 USD |
|
13 years ago
Jul 01, 2011
|
Sell 6 K
USD
|
Turner Stephen W
VP & Chief Technology Officer
|
- 500
|
12 USD |
|
13 years ago
Jul 05, 2011
|
Sell 450 K
USD
|
Turner Stephen W
VP & Chief Technology Officer
|
- 37400
|
12.0313 USD |
|
13 years ago
Jul 06, 2011
|
Sell 362 K
USD
|
Turner Stephen W
VP & Chief Technology Officer
|
- 30000
|
12.0687 USD |
7. News
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Cathie Wood saw her investments rally in the second half of 2024 after a slow start. The co-founder, CEO, and primary stock picker for Ark Invest is hoping to jump ahead of the market early this year.
fool.com
- 1 week ago
PacBio to Present at 43rd Annual J.P. Morgan Healthcare Conference
MENLO PARK, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be presenting at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025, at 4:30 PM PT (7:30 PM ET) in San Francisco, California.
globenewswire.com
- 2 weeks ago
Reasons to Retain PacBio Stock in Your Portfolio for Now
PACB continues to deliver growth from its unique technologies amid business seasonality concerns.
zacks.com
- 1 month ago
Cathie Wood's Ark Invest Bets Big On Biotech Again As Pacific Biosciences Grabs Spotlight
Ark Invest CEO Cathie Wood is doubling down on genomics.
benzinga.com
- 1 month ago
Pacific Biosciences' Cost Cuts Won't Offset Rising Competition
Pacific Biosciences of California stock surged 50% since August despite a 24% YoY revenue decline and deteriorating gross margins due to increased costs and pricing pressures. Q3 revenue of $40 million missed analyst estimates, with SG&A expenses surpassing total revenue and gross profit margins remaining low at 28%. Pacific Biosciences has made significant cuts in R&D, which may harm long-term growth given the rapid technological advancements in the genomic market.
seekingalpha.com
- 2 months ago
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
The rock star money manager is starting to roll with the rallying market.
fool.com
- 2 months ago
PacBio price target lowered to $6 from $7 at Scotiabank
Scotiabank lowered the firm's price target on PacBio to $6 from $7 and keeps an Outperform rating on the shares. The firm lowered its FY24 and FY25 revenue estimates following the company's Q3 update, the analyst tells investors. The firm's longer-term outlook for the company, however, remains intact, believing the company is highly differentiated and the recently accelerated pace of product innovations place the company in a good position for outsized growth.
https://thefly.com
- 2 months ago
PacBio to Present at Upcoming Investor Conferences
MENLO PARK, Calif., Nov. 08, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be participating in the following upcoming investor conferences:
globenewswire.com
- 2 months ago
PACB Stock Falls Despite Q3 Earnings Beat, Revenues Decline Y/Y
PacBio Q3 2024 revenues decline year over year. However, Consumable, and Service and other revenues increase.
zacks.com
- 2 months ago
Pacific Biosciences of California, Inc. (PACB) Q3 2024 Earnings Call Transcript
Pacific Biosciences of California, Inc. (NASDAQ:PACB ) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET Company Participants Todd Friedman - Senior Director of Investor Relations Christian Henry - President and Chief Executive Officer Susan Kim - Chief Financial Officer Conference Call Participants Tejas Savant - Morgan Stanley Kyle Nixon - Canaccord Mason Carrico - Stephens Dan Brennan - TD Cowen Jack Meehan - Nephron Research Subbu Nambi - Guggenheim Securities Madeline Mollman - Wolfe Research Operator Good day and welcome to the PacBio Third Quarter 2024 Earnings Conference Call. All participants will be in a listen-only mode.
seekingalpha.com
- 2 months ago
Pacific Biosciences (PACB) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Pacific Biosciences (PACB) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
zacks.com
- 2 months ago
Pacific Biosciences of California (PACB) Reports Q3 Loss, Misses Revenue Estimates
Pacific Biosciences of California (PACB) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.20. This compares to loss of $0.27 per share a year ago.
zacks.com
- 2 months ago
8. Profile
Summary
Pacific Biosciences of California, Inc. PACB
COUNTRY
US
INDUSTRY
Medical - Devices
MARKET CAP
$ 449 M
Dividend Yield
0.00%
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. The company serves research institutions; commercial laboratories; genome centers; public health labs, hospitals and clinical research institutes, contract research organizations, and academic institutions; pharmaceutical companies; and agricultural companies. It markets its products through a direct sales force in North America and Europe, as well as through distribution partners in Asia, Europe, the Middle East, Africa, and Latin America. Pacific Biosciences of California, Inc. has a development and commercialization agreement with Invitae Corporation. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.
Contact
1305 O’Brien Drive, Menlo Park, CA, 94025
https://www.pacb.com
IPO
Date
Oct. 27, 2010
Employees
796
Officers
Dr. Stephen Turner Ph.D.
Co-Founder
Mr. Christian O. Henry M.B.A.
President, Chief Executive Officer, Interim Chief Financial Officer & Director
Ms. Natalie Welch
Chief People Officer
Mr. Mark Van Oene Ph.D.
Chief Operating Officer
Dr. Brett Atkins J.D., Ph.D.
General Counsel & Corporate Secretary
Ms. Michele Farmer CPA
Vice President & Chief Accounting Officer